Free Trial
→ This company will win the AI race (From Porter & Company) (Ad) Free HKMPF Stock Alerts

Hikma Pharmaceuticals (HKMPF) Short Interest Ratio & Short Volume

Hikma Pharmaceuticals logo
$24.47 0.00 (0.00%)
(As of 12/2/2024 ET)
Compare

Hikma Pharmaceuticals Short Interest Data

Hikma Pharmaceuticals (HKMPF) has a short interest of 1.53 million shares. This marks a 1.13% increase in short interest from the previous month. The short interest ratio (days to cover) is 15,268.0, indicating that it would take 15,268.0 days of the average trading volume of 51 shares to cover all short positions.

Current Short Interest
1,526,800 shares
Previous Short Interest
1,509,700 shares
Change Vs. Previous Month
+1.13%
Dollar Volume Sold Short
$34.44 million
Short Interest Ratio
15,268.0 Days to Cover
Last Record Date
November 15, 2024
Outstanding Shares
220,230,000 shares
Percentage of Shares Shorted
0.69%
Today's Trading Volume
0 shares
Average Trading Volume
51 shares
Today's Volume Vs. Average
0%
Short Selling Hikma Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

HKMPF Short Interest Over Time

HKMPF Days to Cover Over Time

HKMPF Percentage of Float Shorted Over Time

Hikma Pharmaceuticals Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/20241,526,800 shares $34.44 million +1.1%N/A15268 $22.56
10/31/20241,509,700 shares $37.85 million -2.9%N/A0 $25.07
10/15/20241,554,200 shares $39.10 million +0.7%N/A15542 $25.16
9/30/20241,544,100 shares $39.68 million -0.3%N/A15441 $25.70
9/15/20241,547,900 shares $39.78 million +0.4%N/A15479 $25.70
8/31/20241,541,500 shares $40.02 million -2.1%N/A2202.1 $25.96
8/15/20241,574,300 shares $41.04 million -17.0%N/A1211 $26.07
7/31/20241,896,300 shares $45.51 million +0.2%N/A3792.6 $24.00
7/15/20241,892,500 shares $44.86 million +0.1%N/A6308.3 $23.70
6/30/20241,891,200 shares $47.75 million +1.0%N/A18912 $25.25
6/15/20241,872,400 shares $47.28 million +0.5%N/A3744.8 $25.25
5/31/20241,862,300 shares $45.63 million -0.1%N/A18623 $24.50
5/15/20241,863,300 shares $45.65 million +0.7%N/A6211 $24.50
4/30/20241,849,700 shares $41.30 million +6.2%N/A9248.5 $22.33
4/15/20241,741,900 shares $42.24 million 0.0%N/A5806.3 $24.25
3/31/20241,742,100 shares $40.71 million +0.2%N/A8710.5 $23.37
3/15/20241,739,000 shares $40.64 million 0.0%N/A8695 $23.37
2/29/20241,739,100 shares $46.09 million +0.1%N/A5797 $26.50
2/15/20241,737,700 shares $43.44 million -1.2%N/A2172.1 $25.00
1/15/20241,756,000 shares $43.30 million No ChangeN/A8780 $24.66
12/31/20231,756,000 shares $40.01 million -10.0%N/A2676.8 $22.79
12/15/20231,951,100 shares $43.02 million +0.1%N/A19511 $22.05
11/30/20231,948,900 shares $42.95 million +0.3%N/A721.8 $22.04
11/15/20231,944,100 shares $43.28 million +0.5%N/A4860.3 $22.26
10/31/20231,934,300 shares $45.24 million +4.5%N/A4835.8 $23.39
10/15/20231,850,400 shares $46.97 million +5.5%N/A9252 $25.38
9/30/20231,754,100 shares $47.36 million -1.1%N/A17541 $27.00
9/15/20231,774,300 shares $47.91 million -0.1%N/A17743 $27.00
8/31/20231,775,300 shares $47.93 million +0.1%N/A1894.6 $27.00
8/15/20231,774,500 shares $46.94 million +0.1%N/A4436.3 $26.45
7/31/20231,773,300 shares $46.90 million +13.1%N/A479.3 $26.45
7/15/20231,567,500 shares $36.24 million 0.0%N/A1045 $23.12
6/30/20231,567,700 shares $36.21 million -8.0%N/A7838.5 $23.10
6/15/20231,703,900 shares $40.89 million +0.4%N/A8519.5 $24.00
5/31/20231,697,100 shares $39.03 million -0.3%N/A5657 $23.00
5/15/20231,702,000 shares $38.96 million -0.7%N/A17020 $22.89
4/30/20231,714,200 shares $39.72 million +0.4%N/A2857 $23.17
4/15/20231,707,400 shares $35.24 million +11.9%N/A17074 $20.64
3/31/20231,526,500 shares $30.94 million -2.7%N/A1908.1 $20.27
3/15/20231,569,000 shares $32.38 million -0.2%N/A2241.4 $20.64
This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.
2/28/20231,571,400 shares $33.20 million +0.3%N/A3928.5 $21.13
2/15/20231,567,000 shares $32.67 million -0.9%N/A3134 $20.85
1/31/20231,580,400 shares $29.82 million +0.6%N/A0 $18.87
1/15/20231,571,500 shares $29.65 million -0.6%N/A0 $18.87
12/30/20221,581,500 shares $29.84 million +0.0%N/A3953.8 $18.87
12/15/20221,581,200 shares $29.84 million -0.1%N/A15812 $18.87
11/30/20221,582,800 shares $22.62 million -0.3%N/A3165.6 $14.29
11/15/20221,588,000 shares $22.69 million +0.3%N/A15880 $14.29
10/31/20221,582,900 shares $22.62 million +0.2%N/A3165.8 $14.29
10/15/20221,579,400 shares $22.55 million +0.4%N/A493.6 $14.28
9/30/20221,572,800 shares $21.64 million +0.2%N/A1966 $13.76
9/15/20221,569,100 shares $23.32 million +114.5%N/A412.9 $14.86
8/31/2022731,700 shares $10.87 million No ChangeN/A385.1 $14.86
8/15/2022731,700 shares $14.20 million +0.5%N/A7317 $19.41
7/31/2022727,800 shares $14.62 million +0.5%N/A7278 $20.09
7/15/2022724,400 shares $14.22 million +54.8%N/A2414.7 $19.63
6/30/2022468,100 shares $8.51 million +0.3%N/A173.4 $18.19
6/15/2022466,700 shares $9.72 million +16.2%N/A4667 $20.82
5/31/2022401,700 shares $8.36 million +3,454.9%N/A0 $20.82
5/15/202211,300 shares $235,266.00 -86.6%N/A4.7 $20.82
4/30/202284,600 shares $2.37 million -1.7%N/A282 $28.00
4/15/202286,100 shares $2.41 million -1.3%N/A861 $28.00
3/31/202287,200 shares $2.44 million +87.1%N/A79.3 $28.00
3/15/202246,600 shares $1.13 million +639.7%N/A66.6 $24.30
2/28/20226,300 shares $176,400.00 -19.2%N/A21 $28.00
2/15/20227,800 shares $210,600.00 -41.8%N/A78 $27.00
1/31/202213,400 shares $361,130.00 -1.5%N/A33.5 $26.95
1/15/202213,600 shares $384,200.00 -26.5%N/A34 $28.25
12/31/202118,500 shares $529,840.00 -66.5%N/A46.3 $28.64
12/15/202155,200 shares $1.60 million +1,477.1%N/A276 $28.92
11/30/20213,500 shares $112,000.00 +169.2%N/A35 $32.00
11/15/20211,300 shares $41,600.00 +44.4%N/A13 $32.00
10/29/2021900 shares $28,800.00 -35.7%N/A9 $32.00
10/15/20211,400 shares $44,800.00 +7.7%N/A14 $32.00
9/30/20211,300 shares $44,525.00 -23.5%N/A13 $34.25
9/15/20211,700 shares $58,310.00 -97.8%N/A17 $34.30
8/31/202177,600 shares $2.66 million -72.7%N/A388 $34.30
8/13/2021284,000 shares $9.94 million -13.2%N/A946.7 $35.00
7/30/2021327,200 shares $11.99 million -11.1%N/A218.1 $36.65
7/15/2021368,000 shares $12.69 million -31.2%N/A613.3 $34.49
6/30/2021534,900 shares $17.65 million +1.5%N/A2674.5 $33.00
6/15/2021526,900 shares $18.05 million +11.8%N/A50.7 $34.25
5/28/2021471,200 shares $16.44 million -11.3%N/A785.3 $34.90
5/14/2021530,900 shares $17.20 million +1.9%N/A1327.3 $32.39
4/30/2021520,800 shares $17.37 million +71.7%N/A1041.6 $33.35
4/15/2021303,400 shares $10.01 million -19.7%N/A505.7 $33.00
3/31/2021377,700 shares $11.65 million -26.6%N/A1259 $30.85
3/15/2021514,700 shares $16.32 million +3.1%N/A735.3 $31.70
2/26/2021499,200 shares $16.27 million -0.8%N/A1664 $32.60
2/12/2021503,000 shares $16.10 million +90.2%N/A628.8 $32.00
This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.
1/29/2021264,500 shares $9.06 million +3.1%N/A661.3 $34.25
1/15/2021248,500 shares $8.80 million +5.2%N/A1242.5 $35.40
12/31/2020248,500 shares $8.54 million No ChangeN/A2485 $34.38
12/15/2020248,500 shares $8.41 million +5.2%N/A1242.5 $33.85
11/30/2020236,300 shares $8.24 million -0.5%N/A94.5 $34.86
11/15/2020237,500 shares $8.13 million +1.8%N/A593.8 $34.23
10/30/2020233,400 shares $7.92 million -20.9%N/A1167 $33.93
10/15/2020295,100 shares $10.33 million -0.5%N/A491.8 $35.00
9/30/2020296,700 shares $9.71 million +0.7%N/A185.4 $32.73
9/15/2020294,700 shares $10.17 million -9.6%N/A50.8 $34.50
8/31/2020326,000 shares $10.17 million -41.6%N/A296.4 $31.19
8/14/2020558,500 shares $16.25 million +16.6%N/A797.9 $29.10
7/31/2020479,200 shares $13.23 million +2.6%N/A1597.3 $27.60
7/15/2020467,000 shares $12.38 million +5.7%N/A311.3 $26.50
6/30/2020441,900 shares $12.15 million -13.4%N/A192.1 $27.50
6/15/2020510,300 shares $14.29 million -4.6%N/A2551.5 $28.00
5/29/2020535,100 shares $17.12 million -4.7%N/A594.6 $32.00
5/15/2020561,500 shares $16.79 million -9.1%N/A467.9 $29.90
4/30/2020617,700 shares $18.53 million -2.5%N/A166.9 $30.00
4/15/2020633,700 shares $18.03 million +11.9%N/A81.2 $28.45
3/31/2020566,400 shares $16.09 million +4.6%N/A145.2 $28.40
3/13/2020541,300 shares $14.56 million -4.4%N/A902.2 $26.90
2/28/2020566,200 shares $13.82 million +5.8%N/A5662 $24.40
2/14/2020535,000 shares $13.11 million +12.9%N/A1783.3 $24.50
1/31/2020473,700 shares $11.56 million +4.3%N/A128 $24.40
1/15/2020454,400 shares $10.45 million +2.2%N/A4544 $23.00
12/31/2019444,500 shares $10.22 million +19.9%N/A4445 $23.00

HKMPF Short Interest - Frequently Asked Questions

What is Hikma Pharmaceuticals' current short interest?

Short interest is the volume of Hikma Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 1,526,800 shares of HKMPF short. Learn More on Hikma Pharmaceuticals' current short interest.

What is a good short interest ratio for Hikma Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HKMPF shares currently have a short interest ratio of 15,268.0. Learn More on Hikma Pharmaceuticals's short interest ratio.

Is Hikma Pharmaceuticals' short interest increasing or decreasing?

Hikma Pharmaceuticals saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,526,800 shares, an increase of 1.1% from the previous total of 1,509,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Hikma Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "private households" compare to Hikma Pharmaceuticals: Aspen Pharmacare Holdings Limited (0.00%), Beach Energy Limited (0.00%), China CITIC Bank Co. Limited (0.00%), Hino Motors, Ltd. (0.00%), Marui Group Co., Ltd. (0.00%), Morgan Advanced Materials plc (0.00%), NSK Ltd. (0.00%), and

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks.

What does it mean to sell short Hikma Pharmaceuticals stock?

Short selling HKMPF is an investing strategy that aims to generate trading profit from Hikma Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Hikma Pharmaceuticals?

A short squeeze for Hikma Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HKMPF, which in turn drives the price of the stock up even further.

How often is Hikma Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HKMPF, twice per month. The most recent reporting period available is November, 15 2024.



Related Companies
Short Interest Tools

This page (OTCMKTS:HKMPF) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
Your bank is lying to you.
You might think you have your money in a high-yield savings account, but do you really? The national average A...
MyBankTracker | Sponsored
How this >10-cent coin is going to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
Is NVDA a sell? Buy this stock instead before Dec 3
After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...
Chaikin Analytics | Sponsored
Most People Are Dead Wrong.
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...
Brownstone Research | Sponsored